Researchers reported in a recent case report on a man who got an mRNA-based COVID-19 vaccine that it “may provoke immune-mediated hepatitis.” Although researchers stated that such a scenario is acknowledged as a “rare adverse event not found in early studies,” the case study does not indicate how prevalent such a case would be. The instance of a 52-year-old German man who experienced acute hepatitis—liver inflammation—two to three weeks after receiving an mRNA-based COVID-19 vaccine from Pfizer-BioNTech is described in the article, which was published in the Journal of Hepatology in late April (the BNT163b2 vaccine). After the individual received the COVID-19 vaccination and developed severe hepatitis, researchers discovered that highly activated T cells “accumulate and are uniformly distributed in the different locations” of his liver. T cells are white blood cells that play an important role in the immune … Continue reading Yet Another Adverse Effect Identified With Experimental COVID-19 MRNA Injections.